Risk Factors for Perinatal Transmission of Human Immunodeficiency Virus Type 1 in Women Treated with ZidovudineLynne Mofenson, George J. Nemo, Jack Moye et al.|New England Journal of Medicine|1999Cited by 553
Efficacy of Zidovudine and Human Immunodeficiency Virus (HIV) Hyperimmune Immunoglobulin for Reducing Perinatal HIV Transmission from HIV‐Infected Women with Advanced Disease: Results of Pediatric AIDS Clinical Trials Group Protocol 185E. Richard Stiehm, Hunter Hammill, John S. Lambert et al.|The Journal of Infectious Diseases|1999Cited by 149
Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudineJohn S. Lambert, Mary Glenn Fowler, D. Heather Watts et al.|AIDS|2000Cited by 80